Abstract
Background: Nanocarriers have been a part of drug delivery for some decades now. Due to the enormous advantages offered by them, they are replacing the conventionally available systems.
Objective: The objective of the current review is to focus wider applications of these nanocarriers in drug delivery, diagnosis, imaging, and targeting as well. It also focuses on the different types of nanocarriers, method of preparation, characterization and most advanced uses or application in medicine.
Methods: Literature has been reviewed intensely. Data from various sources like NCBI PubMed and other valued journals have been reviewed thoroughly. Various research investigations related to nanocarriers systems have been compiled.
Results: Selection of the nanocarriers type as well as their composition depends upon the disease and the application for which it is to be used. Nanocarriers have been investigated for various diseases such as cancer drug delivery, cardiovascular drug delivery, insulin delivery, antimalarial drug delivery, central nervous system drug delivery, ophthalmic, pulmonary and brain delivery, etc.
Conclusion: Nanotherapy has led to the advancement in the delivery of chemotherapeutic drugs in cancer because of their characteristic enhanced permeation and retention in the tumor tissue. Also, its applications in various other aspects of therapeutics have been extraordinary and much more is yet to be explored.
Keywords: Nanotechnology, nanocarriers, nanotherapy, cancer drug delivery, cardiovascular, chemotherapeutic.
Graphical Abstract
Current Nanomedicine
Title:Nanocarriers For Drug Delivery: Mini Review
Volume: 8 Issue: 2
Author(s): Vishal Girdhar, Shalini Patil, Saswata Banerjee and Gautam Singhvi*
Affiliation:
- Department of Pharmacy, Industrial Research Laboratory, Birla Institute of Technology and Science, Pilani, Rajasthan,India
Keywords: Nanotechnology, nanocarriers, nanotherapy, cancer drug delivery, cardiovascular, chemotherapeutic.
Abstract: Background: Nanocarriers have been a part of drug delivery for some decades now. Due to the enormous advantages offered by them, they are replacing the conventionally available systems.
Objective: The objective of the current review is to focus wider applications of these nanocarriers in drug delivery, diagnosis, imaging, and targeting as well. It also focuses on the different types of nanocarriers, method of preparation, characterization and most advanced uses or application in medicine.
Methods: Literature has been reviewed intensely. Data from various sources like NCBI PubMed and other valued journals have been reviewed thoroughly. Various research investigations related to nanocarriers systems have been compiled.
Results: Selection of the nanocarriers type as well as their composition depends upon the disease and the application for which it is to be used. Nanocarriers have been investigated for various diseases such as cancer drug delivery, cardiovascular drug delivery, insulin delivery, antimalarial drug delivery, central nervous system drug delivery, ophthalmic, pulmonary and brain delivery, etc.
Conclusion: Nanotherapy has led to the advancement in the delivery of chemotherapeutic drugs in cancer because of their characteristic enhanced permeation and retention in the tumor tissue. Also, its applications in various other aspects of therapeutics have been extraordinary and much more is yet to be explored.
Export Options
About this article
Cite this article as:
Girdhar Vishal , Patil Shalini , Banerjee Saswata and Singhvi Gautam *, Nanocarriers For Drug Delivery: Mini Review, Current Nanomedicine 2018; 8 (2) . https://dx.doi.org/10.2174/2468187308666180501092519
DOI https://dx.doi.org/10.2174/2468187308666180501092519 |
Print ISSN 2468-1873 |
Publisher Name Bentham Science Publisher |
Online ISSN 2468-1881 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Alogliptin; A Review of a New Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for the Treatment of Type 2 Diabetes Mellitus
Cardiovascular & Hematological Disorders-Drug Targets CD31+ Circulating Angiogenic Cell Number and Subtypes are Reduced in Individuals with Chronic Stroke
Current Neurovascular Research The Role of IGF-1 Receptor and Insulin Receptor Signaling for the Pathogenesis of Alzheimers Disease: From Model Organisms to Human Disease
Current Alzheimer Research Zinc and its Specific Transporters as Potential Targets in Airway Disease
Current Drug Targets Rheumatoid Foot and Ankle Surgery
Current Rheumatology Reviews Cell-Selective Mitochondrial Targeting: Progress in Mitochondrial Medicine
Current Drug Delivery The Regulatory Roles of Mitogen-Activated Protein Kinase (MAPK) Pathways in Health and Diabetes: Lessons Learned from the Pancreatic β-Cell
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Glycosphingolipid Clusters as Organizers of Plasma Membrane Rafts and Caveolae
Current Organic Chemistry Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Virtual Screening Based Discovery of PTP1B Inhibitors and Their Biological Evaluations
Letters in Drug Design & Discovery Is Innate Immunity and Inflammasomes Involved in Pathogenesis of Amyotrophic Lateral Sclerosis (ALS)?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Gadd45 Proteins as Critical Signal Transducers Linking NF-κB to MAPK Cascades
Current Cancer Drug Targets The PI3K/Akt Pathway: Recent Progress in the Development of ATP-Competitive and Allosteric Akt Kinase Inhibitors
Current Cancer Drug Targets Melatonin Regulates Angiogenic and Inflammatory Proteins in MDA-MB-231 Cell Line and in Co-culture with Cancer-associated Fibroblasts
Anti-Cancer Agents in Medicinal Chemistry Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF): Surgical Adjuvants, Preparations for In Situ Regenerative Medicine and Tools for Tissue Engineering
Current Pharmaceutical Biotechnology The Secretin/Pituitary Adenylate Cyclase-Activating Polypeptide/ Vasoactive Intestinal Polypeptide Superfamily in the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Understanding Trastuzumab Resistance in HER2 Positive Breast Cancer and Further Therapeutic Options
Current Cancer Therapy Reviews Therapeutic Challenges in Neuroendocrine Tumors
Anti-Cancer Agents in Medicinal Chemistry Utilization of the DaT-SCAN SPECT in the Diagnosis of Parkinson's Disease in Older Subjects
Letters in Drug Design & Discovery Structure - Function Analysis of Peptide Analogs of SQSPA with Respect to α-glucosidase and α-amylase Inhibition
Protein & Peptide Letters